WALD - NASDAQ
Waldencast plc
$1.71
-7.1%Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
At a Glance
Live SnapshotWaldencast plc Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Cash Flow Quality Insight
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
Waldencast plc Cash Flow Statement
WALD • NASDAQ
| Waldencast plc Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||
-229.7M | -48.6M | -90M | -116.6M | -19.6M | -2.4M | |
59.2M | 60M | 60.5M | 35.2M | 13.9M | 13.4M | |
-17.4M | -1.2M | -7M | -5.7M | 9.4M | -3M | |
0.0 | 9.4M | 9.2M | 7.7M | 0.0 | 0.0 | |
173.2M | -21.6M | -2.6M | 27.6M | -761K | 798K | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (9K) | |
2M | -6.8M | 95K | -33.1M | 588K | -16.2M | |
-12.8M | -8.8M | -29.8M | -85M | 3.5M | -7.4M | |
INVESTING ACTIVITIES | ||||||
-3.7M | -3M | -2M | -2.5M | -1.3M | -1.7M | |
-2.6M | (0.0) | (0.0) | -587.7M | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | -44.4M | (0.0) | (0.0) | |
0.0 | 92K | 52K | 44.9M | 0.0 | 0.0 | |
82.5M | 0.0 | 0.0 | 44.4M | -2.5M | 0.0 | |
(76.2M) | -2.9M | -2M | -545.3M | -3.8M | -1.7M | |
FINANCING ACTIVITIES | ||||||
0.0 | 0.0 | 70M | 0.0 | 0.0 | 0.0 | |
-46.8M | 6.1M | -21.9M | 169.3M | 13.5M | 17.4M | |
(0.0) | (0.0) | (0.0) | (0.0) | -2M | -2M | |
-451K | -530K | -3.7M | 464.1M | -6.4M | -1M | |
-47.2M | 5.6M | 44.3M | 633.3M | 5.2M | 14.3M | |
CASH FLOW SUMMARY | ||||||
-601K | -116K | -147K | -6.3M | -32K | 0.0 | |
15.6M | -6.3M | 12.4M | -3.3M | 4.9M | 5.2M | |
16.3M | 22.6M | 10.2M | 13.4M | 8.6M | 3.4M | |
31.9M | 16.3M | 22.6M | 10.2M | 13.4M | 8.6M | |
-16.2M | -11.8M | -31.8M | -87.5M | 2.2M | -9.1M |
SEC Filings
WALD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
6-K 6-K 2026 Q2 Q2 | June 01, 2026 | June 01, 2026 | 2026 | |
6-K 6-K 2026 Q2 Q2 | April 28, 2026 | April 28, 2026 | 2026 | |
6-K 6-K 2025 Q4 Q4 | March 13, 2026 | December 31, 2025 | 2025 | |
20-F 20-F 2025 FY FY | March 13, 2026 | December 31, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | March 11, 2026 | December 31, 2025 | 2025 | |
6-K 6-K 2026 Q1 Q1 | January 15, 2026 | January 15, 2026 | 2026 | |
6-K 6-K 2025 Q4 Q4 | December 19, 2025 | December 19, 2025 | 2025 | |
6-K 6-K 2025 Q3 Q3 | November 24, 2025 | September 30, 2025 | 2025 | |
6-K 6-K 2025 Q2 Q2 | November 24, 2025 | June 30, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | November 14, 2025 | November 14, 2025 | 2025 |
Related Guides
Continue your WALD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.